KDR and neoplasm: Quantification of microvascular density (MVD) in the tumor tissues showed that the administration of Cas9 mRNA/VEGFR2 sgRNA encapsulated by LNPs (G3 and G4) significantly reduced MVD compared to PBS or scrambled sgRNA treated groups (G1 and G2), indicating a pronounced antiangiogenic effect (Fig. 5h).